Cercar
01/08/2021
Pregnancy in Pateints With Exstrophy-Epispadias Complex: Are Higher Rates of Complications and Spontaneous Abortion Inevitable?
Quiroz, Y, Llorens, E, Novoa, R, Motta, G, Llurba, E, Porta, O, Parra, J, Ballarin, J, Palou, J, Bujons, A. Pregnancy in Pateints With Exstrophy-Epispadias Complex: Are Higher Rates of Complications and Spontaneous Abortion Inevitable?. UROLOGY. 2021; 154DOI:10.1016/j.urology.2021.01.061. PMID:33662406. IF:2.633(Q3/7D).
01/08/2021
Robotic Peritoneal Flap Revision of Gender Affirming Vaginoplasty: a Novel Technique for Treating Neovaginal Stenosis Abortion Inevitable? REPLY
Tur, AB. Robotic Peritoneal Flap Revision of Gender Affirming Vaginoplasty: a Novel Technique for Treating Neovaginal Stenosis Abortion Inevitable? REPLY. UROLOGY. 2021; 154DOI:10.1016/j.urology.2021.01.063. PMID:34389079. IF:2.633(Q3/7D).
01/07/2021
Percutaneous Nephrolithotomy in Horseshoe Kidneys: Results of a Multicentric Study
Vicentini, FC, Mazzucchi, E, Gokce, MI, Sofer, M, Tanidir, Y, Sener, TE, Melo, PAD, Eisner, B, Batter, TH, Chi, T, Armas-Phan, M, Scoffone, CM, Cracco, CM, Perez, BOM, Angerri, O, Emiliani, E, Maugeri, O, Stern, K, Batagello, CA, Monga, M. Percutaneous Nephrolithotomy in Horseshoe Kidneys: Results of a Multicentric Study. JOURNAL OF ENDOUROLOGY. 2021; 35(7)DOI:10.1089/end.2020.0128. PMID:32292038. IF:2.619(Q3/7D).
01/07/2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
Fankhauser, CD, Oldenburg, J, Albers, P, Algaba, F, Bokemeyer, C, Boormans, JL, Fischer, S, Fizazi, K, Gremmels, H, de Castro, JM, Janisch, F, Muilwijk, T, Leao, R, Nicol, D, Nicolai, N, Tandstad, T, Laguna, MP. Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021. EUROPEAN UROLOGY. 2021; 80(1)DOI:10.1016/j.eururo.2021.02.032. PMID:33722419. IF:24.344(Q1/1D).
01/07/2021
Global Variations in the Mineral Content of Bottled Still and Sparkling Water and a Description of the Possible Impact on Nephrological and Urological Diseases
Stoots, SJM, Kamphuis, GM, Geraghty, R, Vogt, L, Henderickx, MMEL, Hameed, BMZ, Ibrahim, S, Pietropaolo, A, Jamnadass, E, Aljumaiah, SM, Hamri, SB, Ventimiglia, E, Traxer, O, Gauhar, V, Keller, EX, De Coninck, V, Durutovic, O, Gadzhiev, NK, Dragos, LB, Sener, TE, Rukin, N, Talso, M, Kallidonis, P, Emiliani, E, Bres-Niewada, E, Scotland, KB, Bhojani, N, Vagionis, A, Piccirilli, A, Somani, BK. Global Variations in the Mineral Content of Bottled Still and Sparkling Water and a Description of the Possible Impact on Nephrological and Urological Diseases. Journal of Clinical Medicine. 2021; 10(13)DOI:10.3390/jcm10132807. PMID:34198985. IF:4.964(Q2/4D).
01/07/2021
Impact of the adherence to medical treatment on the main urinary metabolic disorders in patients with kidney stones
Manzo, BO, Cabrera, JD, Emiliani, E, Sanchez, HM, Eisner, BH, Torres, JE. Impact of the adherence to medical treatment on the main urinary metabolic disorders in patients with kidney stones. Asian Journal Of Urology. 2021; 8(3)DOI:10.1016/j.ajur.2020.07.002. PMID:34401334. IF:(Q/D).
01/07/2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients
Pisano, F, Gontero, P, Sylvester, R, Joniau, S, Serretta, V, Larre, S, Di Stasi, S, van Rhijn, B, Witjes, A, Grotenhuis, A, Colombo, R, Briganti, A, Babjuk, M, Soukup, V, Malmstrom, PU, Irani, J, Malats, N, Baniel, J, Mano, R, Cai, T, Cha, E, Ardelt, P, Varkarakis, J, Bartoletti, R, Dalbagni, G, Shariat, SF, Xylinas, E, Karnes, RJ, Palou, J. Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. Actas Urologicas Espanolas. 2021; 45(6)DOI:10.1016/j.acuro.2020.08.016. PMID:34147426. IF:0.887(Q4/10D).
01/07/2021
Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?
Marra, G, Calleris, G, Alessio, P, Oderda, M, Palou, J, Joniau, S, Piechaud, T, Smelzo, S, Morlacco, A, Sharma, V, Tilki, D, Van der Poel, H, Veerman, H, Karnes, RJ, Gontero, P. Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?. European Urology Focus. 2021; 7(4)DOI:10.1016/j.euf.2020.04.005. PMID:32414618. IF:5.952(Q1/2D).